# CurvaFix, Inc.

> CurvaFix, Inc. is a Bellevue, Washington medical device company that developed the CurvaFix IM Implant - the first new intramedullary technology for pelvic trauma in three decades. Its curved, steerable rodscrew follows the natural shape of the pelvis, enabling strong internal fixation through a single small incision. The device is designed to reduce pain, support early weight-bearing, and speed recovery for patients with high- and low-energy pelvic fractures, including the growing population of elderly patients with fragility fractures of the pelvis.

- **Founded:** 2012
- **Headquarters:** Bellevue, Washington, United States
- **Founders:** Robert Meek, MD (Surgeon Founder & Strategic Medical Advisor), Steve Dimmer (Founding CEO (2012-2023), later strategic advisor)
- **Team size:** 38 employees
- **Products:** CurvaFix IM Implant / Rodscrew System, CurvaFix Smaller-Diameter IM Implant, CurvaFix Low Profile System
- **Notable:** Developed the first new intramedullary pelvic trauma technology in roughly 30 years, Completed the first surgical procedure with the CurvaFix Rodscrew in September 2019, Received FDA 510(k) clearance for the Intramedullary Rodscrew System and, in November 2022, for a smaller-diameter IM Implant

## Products & services

- **CurvaFix IM Implant / Rodscrew System** — A curved, steerable intramedullary implant that follows the natural shape of the pelvis, filling the intramedullary space to provide strong internal fixation through a single small incision. Features a threaded, self-tapping distal end and a driving-torque interface at the proximal end.
- **CurvaFix Smaller-Diameter IM Implant** — A smaller-diameter version of the IM Implant, FDA-cleared in November 2022, expanding the range of patients and pelvic anatomy that can be treated.
- **CurvaFix Low Profile System** — Next-generation low-profile intramedullary nailing system for surgical stabilization of pelvic fractures, designed for less invasive intervention and early weight-bearing.

## Achievements

- Developed the first new intramedullary pelvic trauma technology in roughly 30 years
- Completed the first surgical procedure with the CurvaFix Rodscrew in September 2019
- Received FDA 510(k) clearance for the Intramedullary Rodscrew System and, in November 2022, for a smaller-diameter IM Implant
- Closed a $39M Series C in July 2023 led by MVM Partners, bringing total capital raised to roughly $60M
- Cited potential OR cost savings of more than $6,000 per procedure versus bone plate fixation

## Latest updates

- **2023-07** — Closed $39M Series C led by MVM Partners and named Mark Foster president and CEO, succeeding founding CEO Steve Dimmer.
- **2022-11** — Received FDA 510(k) clearance for a smaller-diameter CurvaFix IM Implant for pelvic fracture fixation.
- **2026-06** — Introduced the CurvaFix Low Profile intramedullary nailing system messaging on its site.

## Links

- Website: https://curvafix.com
- LinkedIn: http://www.linkedin.com/company/curvafix-llc
- Twitter/X: https://twitter.com/CurvaFix
- YouTube: https://www.youtube.com/@curvafix5637
- Instagram: https://www.instagram.com/curvafix/
- Facebook: https://www.facebook.com/CurvaFix

---

Profile page: https://yespress.io/curvafix-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-21